Neogen Chemicals Limited (Neogen) Share Price & Stock Analysis

Neogen Chemicals Limited (Neogen) (NSE: NEOGEN, BSE: 542665) is a Thane, Maharashtra-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹8,322 Cr, it ranks #652 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 13 in Custom Synthesis and Specialty CDMO. At ₹2,775.00 (as of 16 Nov 2026), the share price is 3.5% below its 52-week high of ₹2,875.00 and 183.2% above its 52-week low of ₹979.80. The share price is up 93.4% over one year and up 31.3% over three months.

Key Metrics

Current Price₹2,775.00
Market Cap₹8,322 Cr
NSE SymbolNEOGEN
BSE Code542665
SectorMaterials > Chemicals > Speciality Chemicals
Sub-IndustrySpecialty Chemicals > Custom Synthesis and Specialty CDMO
P/E Ratio259.2
Return on Equity3.58%
Return on Assets2.95%
52-Week Range₹979.80 – ₹2,875.00
1-Year Price Change+93.4%
3-Month Price Change+31.3%
Beta (1Y)0.61
Dividend Yield0.04%
HeadquartersThane, Maharashtra
Websitewww.neogenchem.com

Latest Quarterly Results — Q2 FY27

Revenue₹296 Cr
Net Profit₹8 Cr
Net Margin2.8%
EPS (Basic)₹2.96
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Neogen Chemicals Limited (Neogen) Quarterly Revenue and Profit Trend

Neogen Chemicals Limited (Neogen) reported revenue of ₹296 Cr in Q2 FY27, up 41.8% from ₹209 Cr in Q2 FY26 and up 18.2% from ₹250 Cr in Q1 FY27. It posted a net profit of ₹8 Cr for the quarter, against a net profit of ₹3 Cr in Q2 FY26 (up 144.2%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹187 Cr (Q1 FY26) to ₹296 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹296 Cr₹8 Cr2.8%
Q1 FY27₹250 Cr₹17 Cr6.8%
Q4 FY26₹247 Cr₹11 Cr4.6%
Q3 FY26₹220 Cr₹4 Cr1.7%
Q2 FY26₹209 Cr₹3 Cr1.6%
Q1 FY26₹187 Cr₹10 Cr5.5%
Q4 FY25₹203 Cr₹2 Cr1.2%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 53.01% of Neogen Chemicals Limited (Neogen)'s shares as of Sept 2026, against 51.23% in Dec 2025 (+1.78 percentage points). Delivery averaged 40.4% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Neogen Chemicals Limited (Neogen)

Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki co

Products and Services

1. Manufacturing of Speciality Chemicals-This segment manufacturers of bromine and lithium based specialty chemicals. It offers organic chemicals, such as alkyl bromide compounds, dibromo alkane compounds, and bromo chloro alkanes; specialty chemical compounds; grignard reagents; advance intermediates; inorganic bromine compounds; and lithium salts. The company also provides custom synthesis and contract manufacturing services.

Business Segments

1. Manufacturing of Speciality Chemicals-100%

Neogen Chemicals Limited (Neogen) vs Peers — Custom Synthesis and Specialty CDMO

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Anupam Rasayan India Ltd₹13,570 Cr79.65.76%₹806 Cr+20.1%
Neogen Chemicals Limited (Neogen)₹8,322 Cr259.23.58%₹296 Cr+93.4%
Prasol Chemicals Limited₹4,681 Cr58.1—₹413 Cr—
Laxmi Organic Industries Ltd₹4,574 Cr57.24.08%₹1,083 Cr-18.9%
Tatva Chintan Pharma Chem Ltd₹3,871 Cr92.55.53%₹217 Cr+12.2%
Paushak Ltd.₹1,487 Cr38.18.22%₹89 Cr—
Sunshield Chemicals Ltd.₹833 Cr25.217.02%—+12.6%
Chemcon Speciality Chemicals Limited₹733 Cr31.84.80%₹65 Cr-12.8%
Resonance Specialties Ltd.₹327 Cr31.515.15%—+203.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Neogen Chemicals Limited (Neogen)?

Neogen Chemicals Limited (Neogen) is trading at ₹2,775.00, with a market capitalisation of ₹8,322 Cr.

Which sector does Neogen Chemicals Limited (Neogen) belong to?

Neogen Chemicals Limited (Neogen) operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).

What are the key financial ratios of Neogen Chemicals Limited (Neogen)?

Neogen Chemicals Limited (Neogen) has a P/E of 259.2 and a return on equity of 3.58%.

What is the stock symbol of Neogen Chemicals Limited (Neogen)?

Neogen Chemicals Limited (Neogen) is listed on the NSE under the symbol NEOGEN and on the BSE under the scrip code 542665.

How has Neogen Chemicals Limited (Neogen)'s share price moved over the past year?

Neogen Chemicals Limited (Neogen)'s share price is up 93.4% over one year and up 31.3% over three months. Its 52-week range is ₹979.80 to ₹2,875.00.

What were Neogen Chemicals Limited (Neogen)'s latest quarterly results?

In Q2 FY27, Neogen Chemicals Limited (Neogen) reported revenue of ₹296 Cr and net profit of ₹8 Cr, with basic EPS of ₹2.96 (consolidated, parsed from the company's exchange filing).

How have Neogen Chemicals Limited (Neogen)'s revenue and profit changed over the past year?

Neogen Chemicals Limited (Neogen) reported revenue of ₹296 Cr in Q2 FY27, up 41.8% from ₹209 Cr in Q2 FY26 and up 18.2% from ₹250 Cr in Q1 FY27.

What is the promoter holding in Neogen Chemicals Limited (Neogen)?

Promoters held 53.01% of Neogen Chemicals Limited (Neogen)'s shares as of Sept 2026, against 51.23% in Dec 2025 (+1.78 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.